Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 172

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Clinical and patient‐reported outcomes of SPARE – a randomised feasibility study of selective bladder preservation versus radical cystectomy

Open access
Huddart, Robert A., Birtle, Alison, Maynard, Lauren, Beresford, Mark, Blazeby, Jane, Donovan, Jenny, Kelly, John D., Kirkbank, Tony, McLaren, Duncan B., Mead, Graham, Moynihan, Clare, Persad, Raj, Scrase, Christopher, Lewis, Rebecca, Hall, Emma·2017·BJU International

Abstract

Objectives: To test the feasibility of a randomised trial in muscle‐invasive bladder cancer ( MIBC ) and compare outcomes in patients who receive neoadjuvant chemotherapy followed by radical cystectomy ( RC ) or selective bladder preservation ( SBP ), where definitive treatment [ RC or radiotherapy ( RT )] is determined by response to chemotherapy. Patients and Methods: SPARE is a multicentre randomised controlled trial comparing RC and SBP in patients with MIBC staged T2–3 N0 M0, fit for both treatment strategies and receiving three cycles of neoadjuvant chemotherapy. Patients were randomised between RC and SBP before a cystoscopy after cycle three of neoadjuvant chemotherapy. Patients with ≤T1 residual tumour received a fourth cycle of neoadjuvant chemotherapy in both groups, followed by radical RT in the SBP group and RC in in the RC group; non‐responders in both groups proceeded immediately to RC following cycle three. Feasibility study primary endpoints were accrual rate and compliance with assigned treatment strategy. The phase III trial was designed to demonstrate non‐inferiority of SBP in terms of overall survival ( OS ) in patients whose tumours responded to neoadjuvant chemotherapy. Secondary endpoints included patient‐reported quality of life, clinician assessed toxicity, loco‐regional recurrence‐free survival, and rate of salvage RC after SBP . Results: Trial recruitment was challenging and below the predefined target with 45 patients recruited in 30 months (25 RC ; 20 SBP ). Non‐compliance with assigned treatment strategy was frequent, six of the 25 patients (24%) randomised to RC received RT . Long‐term bladder preservation rate was 11/15 (73%) in those who received RT per protocol. OS survival was not significantly different between groups. Conclusions: Randomising patients with MIBC between RC and SBP based on response to neoadjuvant chemotherapy was not feasible in the UK health system. Strong clinician and patient preferences for treatments impacted willingness to undergo randomisation and acceptance of treatment allocation. Due to the few participants, firm conclusions about disease and toxicity outcomes cannot be drawn.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/bju.13900

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 172

Metadata

Authors
Huddart, R. A., Birtle, A., Maynard, L., Beresford, M., Blazeby, J., Donovan, J., Kelly, J. D., Kirkbank, T., McLaren, D. B., Mead, G., Moynihan, C., Persad, R., Scrase, C., Lewis, R., & Hall, E.
Venue
BJU International
Publisher
Wiley
Published
2017-05-29
Volume
120
Issue
5
Pages
639-650
ISSN
  • 1464-4096 (ISSN-L)
  • 1464-410X
OpenAlex
W2607756307
Cited by
172
References
1
FWCI
11.88
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Clinical and patient‐reported outcomes of SPARE – a randomised feasibility study of selective bladder preservation versus radical cystectomy. https://app.cochat.ai/papers/10.1111/bju.13900
The paper
Huddart, R. A., Birtle, A., Maynard, L., Beresford, M., Blazeby, J., Donovan, J., Kelly, J. D., Kirkbank, T., McLaren, D. B., Mead, G., Moynihan, C., Persad, R., Scrase, C., Lewis, R., & Hall, E. (2017). Clinical and patient‐reported outcomes of SPARE – a randomised feasibility study of selective bladder preservation versus radical cystectomy. BJU International. https://doi.org/10.1111/bju.13900

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.